Literature DB >> 15205291

An investigation into general practitioners associated with high patient mortality flagged up through the Shipman inquiry: retrospective analysis of routine data.

Mohammed A Mohammed1, Anthony Rathbone, Paulette Myers, Divya Patel, Helen Onions, Andrew Stevens.   

Abstract

OBJECTIVE: To identify a credible explanation for the excessively high mortality associated with general practitioners who were flagged up by the Shipman inquiry.
DESIGN: Retrospective analysis of routine data.
SETTING: Primary care. PARTICIPANTS: Two general practitioners in the West Midlands who were associated with an unacceptably high mortality of patients during 1993-2000. MAIN OUTCOME MEASURES: Observed and expected number of deaths and deaths in nursing homes.
RESULTS: Preliminary discussions with the general practitioners highlighted deaths in nursing homes as a possible explanatory factor. No relation was found between the expected number of deaths and deaths in nursing homes in each year during 1993-2000 for either general practitioner. In contrast, the magnitude and shape of the curves of a cumulative sum plot for excess number of deaths (observed minus expected) in each year were closely mirrored by the magnitude and shape of the curves of the number of patients dying in nursing homes; and this was reflected in the high correlations (R2 = 0.87 and 0.89) between excess mortality and the number of deaths in nursing homes in each year for the general practitioners. These findings were supported by administrative data.
CONCLUSIONS: The excessively high mortality associated with two general practitioners was credibly explained by a nursing home effect. General practitioners associated with high patient mortality, albeit after sophisticated statistical analysis, should not be labelled as having poor performance but instead should be considered as a signal meriting scientific investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15205291      PMCID: PMC428518          DOI: 10.1136/bmj.328.7454.1474

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  6 in total

1.  Bristol, Shipman, and clinical governance: Shewhart's forgotten lessons.

Authors:  M A Mohammed; K K Cheng; A Rouse; T Marshall
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

2.  The measurement of active errors: methodological issues.

Authors:  R J Lilford; M A Mohammed; D Braunholtz; T P Hofer
Journal:  Qual Saf Health Care       Date:  2003-12

3.  Monitoring mortality rates in general practice after Shipman.

Authors:  Richard Baker; David R Jones; Peter Goldblatt
Journal:  BMJ       Date:  2003-02-01

4.  Following Shipman: a pilot system for monitoring mortality rates in primary care.

Authors:  Paul Aylin; Nicky Best; Alex Bottle; Clare Marshall
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

5.  Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma.

Authors:  Richard Lilford; Mohammed A Mohammed; David Spiegelhalter; Richard Thomson
Journal:  Lancet       Date:  2004-04-03       Impact factor: 79.321

6.  Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery.

Authors:  David Spiegelhalter; Olivia Grigg; Robin Kinsman; Tom Treasure
Journal:  Int J Qual Health Care       Date:  2003-02       Impact factor: 2.038

  6 in total
  12 in total

1.  Investigation into GPs with high patient mortality: situation is even more complicated.

Authors:  Anne M Rothery
Journal:  BMJ       Date:  2004-08-07

2.  Investigation into GPs with high patient mortality: monitoring death rates will become increasingly complex.

Authors:  Julie Billett; Nick Kendall; Peter Old
Journal:  BMJ       Date:  2004-08-07

3.  Was Rodney Ledward a statistical outlier? Retrospective analysis using routine hospital data to identify gynaecologists' performance.

Authors:  Mike Harley; Mohammed A Mohammed; Shakir Hussain; John Yates; Abdullah Almasri
Journal:  BMJ       Date:  2005-04-15

4.  A practical method for monitoring general practice mortality in the UK: findings from a pilot study in a health board of Northern Ireland.

Authors:  Mohammed A Mohammed; Kathryn Booth; David Marshall; Máire Brolly; Tom Marshall; Kar-Keung Cheng; Martin Hayes; Sandy Fitzpatrick
Journal:  Br J Gen Pract       Date:  2005-09       Impact factor: 5.386

Review 5.  Making use of mortality data to improve quality and safety in general practice: a review of current approaches.

Authors:  Richard Baker; Emma Sullivan; Janette Camosso-Stefinovic; Aly Rashid; Azhar Farooqi; Hanna Blackledge; Justin Allen
Journal:  Qual Saf Health Care       Date:  2007-04

6.  Routine mortality monitoring for detecting mass murder in UK general practice: test of effectiveness using modelling.

Authors:  Bruce Guthrie; Tom Love; Rebecca Kaye; Margaret MacLeod; Jim Chalmers
Journal:  Br J Gen Pract       Date:  2008-05       Impact factor: 5.386

7.  Analysing low-risk patient populations allows better discrimination between high-performing and low-performing hospitals: a case study using inhospital mortality from acute myocardial infarction.

Authors:  Michael Coory; Ian Scott
Journal:  Qual Saf Health Care       Date:  2007-10

8.  Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran.

Authors:  Davood Khalili; Alireza Mosavi-Jarrahi; Fatemeh Eskandari; Yasaman Mousavi-Jarrahi; Farzad Hadaegh; Mohammadali Mohagheghi; Fereidoun Azizi
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

9.  Application of Variable Life Adjusted Displays (VLAD) on Victorian Admitted Episodes Dataset (VAED).

Authors:  Nick Andrianopoulos; Damien Jolley; Sue M Evans; Caroline A Brand; Peter A Cameron
Journal:  BMC Health Serv Res       Date:  2012-08-28       Impact factor: 2.655

10.  A simple insightful approach to investigating a hospital standardised mortality ratio: an illustrative case-study.

Authors:  Mohammed A Mohammed; Andrew J Stevens
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.